Meetings & Events

Meet the Professor: Pancreatogenic Diabetes

June 17, 2021

Session Date and Time:

Saturday, September 11
12:00–12:45 PM EDT

Learning Objectives:

  1. Discuss the relationship of pancreatic disease to the development of diabetes.
  2. Describe the different etiologies for pancreatogenic diabetes.
  3. Outline unique considerations in diabetes management in pancreatogenic diabetes.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Rita R. Kalyani, MD, MHSDr. Kalyani is an Associate Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at Johns Hopkins University School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins.

Dr. Kalyani is an active clinician and sees patients regularly in the Johns Hopkins Comprehensive Diabetes Center. She directs the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program.

A recipient of NIH grant funding, Dr. Kalyani's research focuses on diabetes and aging and investigates accelerated muscle loss, disability, and frailty in older adults with diabetes. Other research interests include sex differences in diabetes and heart disease and physical functioning in other endocrine and metabolic diseases. She has served on the editorial boards of several diabetes research journals and has authored more than 125 peer-reviewed publications.

Dr. Kalyani is a past Chair of the American Diabetes Association’s Professional Practice Committee which is responsible for the annual clinical guidelines statement, “ADA Standards of Medical Care in Diabetes.” She is the Editor-in-Chief of the Johns Hopkins Patient Guide to Diabetes website. Dr. Kalyani currently serves on the Clinical Guidelines Committee for the Endocrine Society.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.